"The U.S. Food and Drug Administration today approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS) either before transplant, or after renal (kidney) transplantation in which there is re"...
Mechanism of Action
NORMOCARB HF™ is a pharmacologically inactive solution. The concentrations of electrolytes are chosen to help to restore plasma levels to physiological concentrations.
NORMOCARB HF™ is used as replacement solution to replace water and electrolytes removed during hemofiltration and hemodiafiltration.
Last reviewed on RxList: 7/6/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Normocarb HF Information
Report Problems to the Food and Drug Administration
Find out what women really need.